Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()

AIM: To assess clinical outcomes according to the immunosuppressive treatment administered to patients with severe SARS-CoV-2 pneumonia and moderate inflammation. METHODS: A retrospective observational cohort study involving 142 patients with severe COVID-19 pneumonia and moderate inflammation divid...

Descripción completa

Detalles Bibliográficos
Autores principales: Aomar-Millán, Ismael Francisco, Salvatierra, Juan, Torres-Parejo, Úrsula, Nuñez-Nuñez, María, Hernández-Quero, José, Anguita-Santos, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142037/
https://www.ncbi.nlm.nih.gov/pubmed/34056111
http://dx.doi.org/10.1016/j.medcle.2021.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142037/
https://www.ncbi.nlm.nih.gov/pubmed/34056111
http://dx.doi.org/10.1016/j.medcle.2021.01.004

Ejemplares similares